<DOC>
	<DOCNO>NCT00114972</DOCNO>
	<brief_summary>The SYNTAX trial design determine best treatment patient complex coronary disease ( block narrow artery right leave side heart ) randomize patient receive either percutaneous coronary intervention ( PCI ) polymer-based paclitaxel-eluting TAXUS stent coronary artery bypass surgery ( CABG ) .</brief_summary>
	<brief_title>SYNTAX Study : TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery Treatment Narrowed Arteries</brief_title>
	<detailed_description>Due introduction drug-eluting stent ( DESs ) improvement therapy percutaneous coronary intervention ( PCI ) coronary artery bypass surgery ( CABG ) patient , PCI challenge CABG gold standard treatment three vessel ( 3VD ) leave main ( LM ) coronary disease . SYNTAX novel , randomize trial nested registry compare PCI paclitaxel-eluting TAXUS stent CABG 3VD LM patient evaluate best treatment patient complex coronary disease . Patients participate center evaluate cardiothoracic surgeon interventional cardiologist . Those patient determine eligible treatment PCI CABG randomize receive either PCI polymer-based paclitaxel-eluting TAXUS stent CABG . Patients determine unsuitable treatment PCI treat CABG enter CABG registry help define patient population stenting continue unacceptable treatment option . Similarly , patient determine unsuitable treatment CABG treat PCI , use interventional technique device without use DES , enter PCI registry help define patient CABG consider inappropriate .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Threevessel disease , leave main disease LM equivalent without 1 , 2 3VD ( leave anterior descend [ LAD ] , leave circumflex [ LCX ] , right coronary artery [ RCA ] territory ) De novo lesion least 50 % stenosis Myocardial ischemia ( stable , unstable , silent ) Prior PCI CABG Acute myocardial infarction ( creatinine kinase &gt; 2x upper limit normal ) Concomitant cardiac valve disease require surgical therapy ( reconstruction replacement ) Participation plan participation another cardiovascular clinical study 1 year followup complete Inability give informed consent due mental condition , mental retardation , language barrier</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Three-vessel coronary artery disease</keyword>
	<keyword>Left main coronary artery disease</keyword>
</DOC>